Stock Market Reviews

LLY (Eli Lilly and Company) News

Get the latest news, insights, and market updates on LLY (Eli Lilly and Company). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Eli Lilly’s (LLY) “a Great Company,” Says Jim Cramer
  We recently published 11 Stocks Jim Cramer Talked About. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Cramer has again started to frequently discuss Eli Lilly and Company (NYSE:LLY) on his morning show. During the year’s first half, the CNBC TV host repeatedly praised the firm’s manufacturing initiatives and […]
  Nov 15, 2025 - $LLY
• Eli Lilly (LLY): Evaluating Valuation as Growth Momentum Builds
  Eli Lilly (LLY) shares have shown steady momentum in recent weeks, not because of a single headline event, but rather due to investor focus on its long-term performance. The company’s growth has generated curiosity about its valuation. See our latest analysis for Eli Lilly. Momentum has clearly been building for Eli Lilly, with the share price climbing 24% over the last month and notching an impressive 38% total shareholder return for the year. Investors are paying attention to the company’s...
  Nov 15, 2025 - $LLY
• Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?
  Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of daily queries through Google Search. Yet its growth extends beyond that core business. Google Cloud has captured a rising slice of the cloud computing sector, trailing only Amazon (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT), while investments in artificial intelligence position it ... Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?
  Nov 15, 2025 - $LLY
• S&P 500 Posts Slight Weekly Rise, Led by Health Care, Energy
  The Standard & Poor's 500 index edged up 0.1% this week as gains led by health care and energy stock
  Nov 14, 2025 - $LLY
• Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?
  Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.
  Nov 14, 2025 - $LLY
• Novo Chairman Blames Board Dropout on Former Employer Pfizer
  The executive, who brought Novo’s first weight-loss shot to market, had to spend part of the meeting explaining why proposed board member, Mikael Dolsten, 67, withdrew just a day ago because of an “issue with a former employer.” “We had very much looked forward to working together with Mikael Dolsten,” Sorensen said. Pfizer’s acquisition of Metsera closed on Thursday making Novo and its US rival clear competitors in the hottest and fastest-growing pharmaceutical market.
  Nov 14, 2025 - $LLY
• Stocks to Watch Recap: Alphabet, Walmart, Eli Lilly, Warner Bros.
  ↗️ Alphabet (GOOGL): Warren Buffett’s Berkshire Hathaway added the Google parent company to its portfolio during the third quarter, according to a new disclosure late Friday. Alphabet shares rose 1.5% afterhours.
  Nov 14, 2025 - $LLY
• Eli Lilly Leads Three Stocks Near Buy Points
  The stock market continued its sell-off Friday, but a few stocks ascended in buy zones and hovered near new highs. Eli  Lilly, for one, hit an all-time high. Another is Valero, which has edged into a buy zone above an entry at 178.43, according to IBD MarketSurge.
  Nov 14, 2025 - $LLY
• Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock
  Shares of Novo Nordisk A/S (NYSE: NVO) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05. Sometimes we see a divergence in share price and sentiment, but with Novo Nordisk they’re actually well correlated. Discussion on Reddit has remained uniformly bearish throughout November. Novo Nordisk is trading more than 50% ... Retail Investors Really Don’t Like Novo Nordisk (NVO) Stock
  Nov 14, 2025 - $LLY
• Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim
  The two drugmakers swiftly denied any affiliation with Mangoceuticals, who claimed it had partnered with them.
  Nov 14, 2025 - $LLY